Early research (Phase 1)Study completedNCT01443663
What this trial is testing
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
Who this might be right for
H5N1 Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 69